DNTH
Dianthus Therapeutics, Inc. /DE/
-0.80 (-0.79%)101.69USD408K成交股數5.7B市值–本益比(近四季)307.7股價營收比+5880.3%營收年增(近四季)2026-11-05下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 11.5M+5880% | 6.3M+439% | 284K-87% | 396K-79% | 193K-78% | 1.2M | 2.2M+135% | 1.9M | 874K | – | 924K | – |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 48.7M | 34.5M | 59.9M | 32.5M | 26.3M | 27.0M | 25.5M | 18.1M | 13.1M | 8.8M | 8.0M | 10.3M |
| 銷售管理費用 | 13.6M | 12.5M | 9.9M | 8.2M | 8.9M | 7.3M | 6.5M | 6.0M | 5.6M | 4.6M | 8.7M | 2.5M |
| 營業利益 | −61.5M+76% | −46.5M+40% | −69.5M+133% | −40.3M+81% | −34.9M+96% | −33.2M+156% | −29.9M+90% | −22.2M+89% | −17.8M | −13.0M | −15.8M | −11.8M |
| 營業利益率 | -532.7% | -742.7% | -24,486.3% | -10,173.7% | -18,096.9% | -2,852.7% | -1,376.6% | -1,191.8% | -2,041.6% | – | -1,705.5% | – |
| 稅後淨利 | −50.2M+59% | −40.8M+38% | −64.4M+156% | −36.8M+109% | −31.6M+130% | −29.5M+180% | −25.2M+71% | −17.6M+58% | −13.7M | −10.6M | −14.8M | −11.1M |
| 淨利率 | -435.1% | -651.8% | -22,687.3% | -9,284.1% | -16,388.1% | -2,537.5% | -1,159.0% | -945.1% | -1,573.0% | – | -1,597.7% | – |
| 稀釋 EPS | -0.90+2% | -0.85+4% | -1.53+107% | -0.97+90% | -0.88+63% | -0.82-105% | -0.74-80% | -0.51-96% | -0.54 | 16.16 | -3.78 | -12.73 |
| 稀釋股數 | 56.0M | 48.0M | 38.6M | 37.8M | 35.8M | 35.8M | 34.2M | 34.2M | 25.7M | 5.2M | 3.9M | 875K |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 111M | 628M | 51.1M | 56.0M | 13.2M | 10.1M | 33.7M | 314M | 330M | 132M | 157M | 40.3M |
| 應收帳款 | 106K | 1.2M | 52K | 5.0M | 39K | 1.0M | 1.4M | 840K | 435K | 294K | 232K | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 1.2B | 1.2B | 531M | 577M | 326M | 349M | 354M | 369M | 382M | 179M | 192M | 78.6M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 41.2M | 45.6M | 37.5M | 31.0M | 23.0M | 20.0M | 16.4M | 10.7M | 9.8M | 10.5M | 14.1M | 4.0M |
| 股東權益 | 1.2B | 1.2B | 493M | 546M | 303M | 329M | 338M | 358M | 373M | 169M | 178M | −61.5M |
| 負債比 | 3.4% | 3.7% | 7.1% | 5.4% | 7.1% | 5.7% | 4.6% | 2.9% | 2.6% | 5.9% | 7.3% | 5.1% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −28.9M+4% | – | – | – | −27.6M | – | – | −14.9M | – | – | – |
| 資本支出 | – | 10K | – | – | – | 24K | – | – | 32K | – | – | – |
| 自由現金流 | – | −28.9M+4% | – | – | – | −27.7M | – | – | −15.0M | – | – | – |
| 折舊攤銷 | – | – | – | – | – | – | – | – | – | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | -460.8% | – | – | – | -2,377.8% | – | – | -1,713.2% | – | – | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 2.0M | -67.3% | −162M | -7,973.3% | -4.20 | −129M |
| FY2024 | 6.2M | +120.6% | −85.0M | -1,362.8% | -2.55 | −78.3M |
| FY2023 | 2.8M | -56.0% | −43.5M | -1,540.9% | -8.45 | −37.0M |
| FY2022 | 6.4M | +334.8% | −28.5M | -443.8% | -32.57 | −29.4M |
| FY2021 | 1.5M | – | −13.1M | -888.1% | -15.01 | −11.2M |
| FY2020 | – | – | −74.9M | –% | -1.71 | −64.4M |
| FY2019 | 0.00 | – | −76.8M | –% | -2.07 | −60.2M |
| FY2018 | 0.00 | – | −57.5M | –% | -3.13 | −49.6M |